Ignite Creation Date:
2024-05-06 @ 3:59 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02425644
Status:
COMPLETED
Last Update Posted:
2023-01-04
First Post:
2015-04-21
Brief Title:
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Sponsor:
Actelion
Organization:
Actelion
Organization Data
Organization:
Actelion
Class:
INDUSTRY
Study ID:
AC-058B301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Actelion
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None